-The Guardian GDP may be an inaccurate indicator in sub-Saharan Africa, which is a concern for those who want to use statistics to help the world's poorest people Even in good financial times, development aid budgets are hardly overflowing. Government leaders and donors must make hard decisions about where to focus their limited resources. How do you decide which countries should get low-cost loans or cheaper vaccines, and which can afford to...

-The Hindu Business Line     The South-West Monsoon is likely to hit the Kerala coast on June 3 this year, the Indian Meteorological Department (IMD) said on The South-West Monsoon is likely to hit the Kerala coast on June 3 this year, the Indian Meteorological Department (IMD) said on Wednesday. The onset forecast has an error margin of four days, IMD said in a statement. The normal onset of monsoon over the Kerala coast...

-The United Nations The Asia-Pacific region, which has overtaken the rest of the world in consumption of raw materials as affluence and manufacturing increase, must boost its resource efficiency or risk losing ground in lifestyle, economic growth and environmental sustainability, according to a UN report released today. From 1970-2008, consumption of construction minerals increased 13.4 times, metal ores and industrial minerals consumption 8.6, fossil fuels 5.4, and biomass 2.7 times, according to...

-Economic and Political Weekly The Saradha group's collapse has possibly bankrupted lakhs of small investors robbing them of their life svaings, and has rendered thousands of its agents jobless. The scam highlights the failure of the government and its regulatory agencies to reign in the mushrooming chit fund companies in West Bengal. It also brings under the scanner the Trinamool Congress' proximity with the tainted group. In the wake of the...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...